Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 672Carcinoma, Non-Small-Cell Lung 461Prostatic Neoplasms 391Neoplasms 383Lung Neoplasms 265Multiple Myeloma 249Colorectal Neoplasms 235Neoplasm Metastasis 216Melanoma 203Ovarian Neoplasms 166Leukemia, Myeloid, Acute 165Pancreatic Neoplasms 156Carcinoma, Renal Cell 142Squamous Cell Carcinoma of Head and Neck 141Lymphoma 137Brain Neoplasms 133Leukemia, Lymphocytic, Chronic, B-Cell 126Glioblastoma 126Recurrence 125Lymphoma, Non-Hodgkin 124Carcinoma, Hepatocellular 119Head and Neck Neoplasms 114Urinary Bladder Neoplasms 111Triple Negative Breast Neoplasms 110Stomach Neoplasms 109Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Uterine Cervical Neoplasms 102Hematologic Neoplasms 99Lymphoma, Follicular 96Sarcoma 95

Interventions

dehydroftorafur 1Radiotherapy 1Radiation 1Platinum 1Fluorouracil 1Docetaxel 1Cisplatin 1Chemoradiotherapy 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Sinonasal undifferentiated carcinoma × 1 year × Clear all
NCT00707473 2026-03-05

Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
31 enrolled

Sinonasal undifferentiated carcinoma, Paranasal Sinus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡